News
QDEL
40.57
-2.59%
-1.08
Weekly Report: what happened at QDEL last week (0210-0214)?
Weekly Report · 12h ago
Penumbra (PEN) Reports Q4: Everything You Need To Know Ahead Of Earnings
Barchart · 14h ago
QuidelOrtho’s Earnings Call: Mixed Sentiment Amidst Revenue Decline
TipRanks · 3d ago
Why QuidelOrtho Stock Bounced More Than 4% Higher Today
The Motley Fool · 3d ago
Where QuidelOrtho Stands With Analysts
Benzinga · 4d ago
QuidelOrtho Price Target Cut to $61.00/Share From $64.00 by RBC Capital
Dow Jones · 4d ago
QuidelOrtho Is Maintained at Outperform by RBC Capital
Dow Jones · 4d ago
RBC Capital Maintains Outperform on QuidelOrtho, Lowers Price Target to $61
Benzinga · 4d ago
QuidelOrtho Stock Gains Following Q4 Earnings Beat, Margins Contract
NASDAQ · 4d ago
Flu Cases Are Surging. What It Means for Healthcare Stocks.
Barron‘s · 4d ago
QuidelOrtho Is Maintained at Neutral by UBS
Dow Jones · 4d ago
QuidelOrtho Price Target Raised to $45.00/Share From $43.00 by UBS
Dow Jones · 4d ago
UBS Maintains Neutral on QuidelOrtho, Raises Price Target to $45
Benzinga · 4d ago
QUIDELORTHO CORP <QDEL.O>: UBS RAISES TARGET PRICE TO $45 FROM $43
Reuters · 4d ago
Analysts Offer Insights on Healthcare Companies: QuidelOrtho (QDEL) and GE Healthcare Technologies Inc (GEHC)
TipRanks · 4d ago
QuidelOrtho (QDEL) Gets a Buy from RBC Capital
TipRanks · 4d ago
QUIDELORTHO CORP <QDEL.O>: RBC CUTS TARGET PRICE TO $61 FROM $64
Reuters · 4d ago
U.S. RESEARCH ROUNDUP-AppLovin, Equinix, Hubspot
Reuters · 4d ago
QuidelOrtho Reports 2024 Results and 2025 Outlook
TipRanks · 4d ago
QuidelOrtho projects $2.6B-$2.81B revenue for 2025 supported by cost savings and margin expansion
Seeking Alpha · 4d ago
More
Webull provides a variety of real-time QDEL stock news. You can receive the latest news about Quidel through multiple platforms. This information may help you make smarter investment decisions.
About QDEL
QuidelOrtho Corporation is engaged in vitro diagnostics, developing and manufacturing intelligent solutions. The Company sells its products directly to end users through a direct sales force and through a network of distributors, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, other point-of-care (POC) settings, blood banks and donor centers, as well as for individual, non-professional, over the counter (OTC) use. The Company provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Connect, Ortho Plus, Ortho Vision, QuickVue, Quidel, QuidelOrtho, QVue, Savanna, Sofia, Solana, Thyretain, Triage, Virena, Vitros among others. It provides support for its customers across more than 130 countries and territories.